康妇炎胶囊结合盆腔炎治疗仪治疗盆腔炎所致慢性盆腔痛临床分析

Clinical Analysis of Treatment of Chronic Pelvic Pain Due to Pelvic Inflammation with Kangfuyan Capsule Combined with Pelvic Inflammatory Apparatus

目的对康妇炎胶囊结合盆腔炎治疗仪治疗盆腔炎所致慢性盆腔痛进行临床分析和探讨。方法方便选取该院2016年12月—2017年6月收治的82例盆腔炎所致慢性盆腔痛患者为对象,按照入院先后分为试验组和对照组,其中每组41例,对照组使用康妇炎胶囊进行治疗,试验组使用康妇炎胶囊结合盆腔炎治疗仪进行治疗,对两组的疗效、治疗情况、不良反应和满意度评分进行比较。结果试验组总体有效39例(95.12%)高于对照组33例(80.49%),差异有统计学意义(P<0.05)。试验组治疗情况(疼痛缓解时间和住院天数)优于对照组,差异有统计学意义(P<0.05)。试验组不良反应情况发生(腹痛、呕吐、头晕)优于对照组,差异有统计学意义(P<0.05)。试验组总体满意39例(95.12%)高于对照组33例(80.49%),差异有统计学意义(P<0.05)。结论康妇炎胶囊结合盆腔炎治疗仪治疗盆腔炎所致慢性盆腔痛疗效显著,不良反应较少,患者较满意。

Objective This paper tries to discuss and analyze the Kangfuyan capsule combined with pelvic inflammation therapeutic apparatus in the treatment of pelvic inflammatory disease caused by chronic pelvic pain. Methods 82 cases of pelvic inflammatory disease caused by chronic pelvic pain treated in this hospital from December 2016 to June 2017 were convenient selected as the research objects, in accordance with the admission, they were divided into the experimental group and the control group, with 41 cases in each group, the control group used Kangfuyan capsules for treatment, the experimental group used Kangfuyan capsule combined pelvic inflammatory disease treatment instrument. The treatment efficacy, situation, adverse reactions and satisfaction scores of two groups were compared. Results The total efficacy of the experimental group was 39 cases（95.12%）, higher than 33 cases（80.49%） in the control group, with significant difference（P〈0.05）.The treatment situation in the experimental group（time of pain relief and hospitalization） were better than the control group,the difference was statistically significant（P〈0.05）. The occurrence of adverse reactions of experimental group（abdominal pain, vomiting, dizziness） were fewer than the control group, the difference was significant（P〈0.05）. The overall satisfaction in the experimental group was 39 cases（95.12%）, higher than that of control group group of 33 cases（80.49%）, with significant difference（P〈0.05）. Conclusion Kangfuyan capsule combined with pelvic inflammation therapeutic apparatus has a significant curative effect in the treatment of pelvic inflammatory disease caused by chronic pelvic pain, with less adverse reaction and high satisfaction rate of the patients.